首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Smg1 haploinsufficiency predisposes to tumor formation and inflammation
【24h】

Smg1 haploinsufficiency predisposes to tumor formation and inflammation

机译:Smg1单倍体不足易导致肿瘤形成和炎症

获取原文
获取原文并翻译 | 示例
       

摘要

SMG1 is a member of the phosphoinosi-tide kinase-like kinase family of proteins whose other members, such as ATM, ATR, and mammalian target of rapa-mycin, are known to play roles in genomic stability and stress responses (1). SMG1 has a well-established role in a process known as nonsense-mediated decay (NMD), by which cells degrade mRNA transcripts that contain premature stop codons and limit the production of truncated proteins that may adversely affect cellular processes (2). SMG1 has also been proposed to play a role in telomere maintenance and the responses to DNA damage, hypoxia, and oxidative stress (3). In this study, we generated a mouse model of Smgl deficiency and found that Smgl KO mice died early during development. Smgl KO embryos were not identified 8.5 d postcoitum.
机译:SMG1是蛋白的磷酸肌醇激酶类似激酶家族的成员,其其他成员,如ATM,ATR和哺乳动物的雷帕霉素靶标,已知在基因组稳定性和应激反应中起作用(1)。 SMG1在称为无意义介导的衰变(NMD)的过程中具有公认的作用,通过该过程,细胞降解包含过早终止密码子的mRNA转录物,并限制可能对细胞过程产生不利影响的截短蛋白的产生(2)。 SMG1也被认为在端粒的维持以及对DNA损伤,缺氧和氧化应激的反应中发挥作用(3)。在这项研究中,我们生成了Smgl缺乏症的小鼠模型,并发现Smgl KO小鼠在发育早期死亡。 Smgl KO胚胎在骨质疏松后8.5天未鉴定。

著录项

  • 来源
  • 作者单位

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia,Centre for Clinical Research, University of Queensland, Herston, QLD 4029, Australia;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia;

    Discipline of Pathology, School of Medicine, University of Western Sydney, and Ingham Institute for Applied Medical Research, Sydney, NSW 1871, Australia;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia;

    Centre for Clinical Research, University of Queensland, Herston, QLD 4029, Australia,Institute for Molecular Bioscience, University of Queensland, St. Lucia, QLD 4072, Australia;

    Centre for Clinical Research, University of Queensland, Herston, QLD 4029, Australia,Institute for Molecular Bioscience, University of Queensland, St. Lucia, QLD 4072, Australia;

    Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia;

    Institute for Molecular Bioscience, University of Queensland, St. Lucia, QLD 4072, Australia;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia;

    The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, QLD4102, Australia;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia;

    Centre for Clinical Research, University of Queensland, Herston, QLD 4029, Australia,School of Dentistry, University of Queensland, Brisbane, QLD4000, Australia;

    lngham Institute, School of Medicine, University of Western Sydney, Sydney, NSW2170, Australia;

    Genome Stability Laboratory, Centre for Chromosome Biology, National University of Ireland, Galway, Ireland;

    Queensland Institute of Medical Research, Brisbane, QLD 4029, Australia,Centre for Clinical Research, University of Queensland, Herston, QLD 4029, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 00:39:51

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号